Life Clinical Research accepts no responsibility for actions taken based on this content.
Some focus on a single probiotic strain marketed as supporting gut or metabolic signaling, while others combine multiple strains and are positioned as promoting overall gut balance
Results for this test available in 10-12 days and will be published in your online dashboard
Mol Metab 30: 72-130, 2019
Personalized dietary advice could help patients set realistic expectations about their outcomes, as GLP-1 medications are not cure-alls, and significant lifestyle changes may be beneficial
Lilly, for instance, already markets tirzepatide and is also banking on orforglipron, a once-daily small-molecule GLP-1 agonist that can be taken as a pill